Dr. Ramakrishna Venugopalan is the Co-Founder and CEO of Continuity Biosciences, with over two decades of leadership in combination product development. Prior to founding Continuity, he led the Combination Product and Drug Delivery teams at AbbVie, where his group developed more than ten categories of delivery systems, including platforms for Skyrizi®, Ozurdex®, Vuity®, and Vyalevä.

At AbbVie, Krishna also spearheaded a global overhaul of the combination product development process, implementing a platform strategy that accelerated timelines and reduced risk. He began his career in academia at the University of Alabama at Birmingham, where he earned his Ph.D. in Biomedical Engineering, and later completed his MBA at MIT Sloan. His prior industry experience includes senior roles at Johnson & Johnson and AbbVie.